Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

New Future Leaders Fellow Dr Beccano-Kelly will lead research into synaptic health over time in neurodegeneration. Watch our video interview with Dayne to find out more about his career to date, successful application and future plans.

Oxford Parkinson's Disease Centre Career Development Fellow in Neurobiology Dr Dayne Beccano-Kelly has been awarded a Future Leaders Fellowship by UK Research and Innovation to start a laboratory at Cardiff University. The UKRI's flagship scheme is designed to establish the careers of world-class research and innovation leaders across the UK. Significant government investment is awarded to enable top class researchers to tackle the major research challenges and drive forward transformative new ideas.

As part of his OPDC Fellowship, Dr Beccano-Kelly designed his project to look at electrophysiological dysfunction in human induced pluripotent Stem cell (iPSC) models of disease and related molecular mechanisms such as calcium homeostasis. Dr Beccano-Kelly said: "This work contributed to my burgeoning belief of the temporal nature of neurodegeneration. Specifically, that signs and symptoms start early and contribute to the late stage neurodegeneration observed."

Director of the Oxford Parkinson's Disease Centre Professor Richard Wade-Martins said: "I am very pleased that Dayne has been awarded a UKRI Future Leaders Fellowship to establish his own laboratory at Cardiff. For the last five years Dayne has held a Career Development Fellowship at the Oxford Parkinson’s Disease Centre and I am delighted that this support has enabled him to make the move to independence. Training and investing in the next generation of researchers is so important to further build strength and capacity in neuroscience in the UK and I have no doubt Dayne will be extremely successful."

From early 2021, Dr Beccano-Kelly's new lab will work on synaptic health over time in neurodegeneration to identify dysfunctional mechanisms and early stage modifiable therapeutic targets. According to Dr Beccano-Kelly: "Identifying such targets will allow for the development of treatments that would halt the progression of the disease before the late stage debilitating and devastating symptoms ever manifest!"

Dr Beccano-Kelly has an important message for postdoctoral fellows looking to take the next step in their career towards independent research: "Collaboration is critical to moving the science and yourselves forwards. Seek it out everywhere you go, never turn your nose up at it but embrace it and see how to make it work!"

Read more about the Fellowship in the UK Research and Innovation website article "UKRI invests £109 million in future leaders".

Similar stories

Just over half of British Indians would take COVID vaccine

EDI News Outreach Postdoctoral Publication Research Riley Group News

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Earliest origins of the forming heart identified

Cardiac Theme Postdoctoral Publication Research

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.

Lukas Krone to represent Oxford at the Global Young Scientists Summit

Awards and Honours EDI News Head of Department's News Students Vyazovskiy Group News

Congratulations are in order for Dr Lukas Krone who is one of just five University of Oxford researchers selected to attend the Global Young Scientists Summit 2021.

Covid-19 lung damage identified in study

Postdoctoral Research

In a new study into the longer-term damage amongst patients recovering from COVID-19, DPAG Research Fellow Dr James Grist of the Tyler Lab has been running a novel scanning technique that shows a dramatic decrease in the ability of the lungs to diffuse gas in to the blood stream after COVID infection. This work may shed light on the problem of breathlessness after COVID infection and help guide us in understanding therapeutic selection and efficacy.

New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy

Cardiac Theme Postdoctoral Publication Research

New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.

Two major BHF awards to Neil Herring pave the way to new treatments for heart attack patients

Awards and Honours Cardiac Theme

Associate Professor Neil Herring has been awarded a Senior Clinical Research Fellowship and a Project grant from the British Heart Foundation to further critical research into the mechanisms behind heart attacks and heart failure and potential drugs to combat them. Given the 50% reduction in research investment this year from the BHF due to the impact of COVID-19, Prof Herring is to be congratulated on these awards.